RET and medullary thyroid gland carcinoma: The RET M918T has been reported as a hotspot somatic mutant molecular in sporadic MTC (about 43%-71% of MTC cases) for decades, and is highly associated with poor prognosis of MTC patients8,22,34,35,52.